Mylan Says Generic Parkinson's Drug Approved

Stock quotes in this article: BMY , MYL  

NEW YORK (AP) — Mylan Inc. said Wednesday it started selling a generic version of Bristol-Myers Squibb Co.'s Parkinson's disease drug Sinemet.

The Food and Drug Administration approved the drug in three doses, the Pittsburgh-based company said. It launched the generic tablets after gaining approval.

Sinemet is a common Parkinson's disease treatment containing two drugs, levodopa and carbidopa. Mylan said U.S. sales totaled $79 million for the 12 months ended June 30.

In morning trading, Mylan shares lost 28 cents to $15.87. Shares of New York-based Bristol-Myers Squibb rose 3 cents to $22.60.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,366.15 1,099.92 2,173.14 33.80
Oil *
77.73
DOWN
86.53
DOWN
9.32
DOWN
11.89
UP
0.57
10 Yr
3.38%
SPDR Gold
118.70
-0.83%
-0.84%
-0.54%
+1.72%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services